PDS Biotechnology Corporation (NASDAQ: PDSB) shares surged 86.47% Tuesday to $0.7442, up $0.3451 from the prior close of $0.3991. The stock opened at $0.4918 and…
September 08, 2026
PRISM Mid-Day Movers: Women’s Health and New Energy are Today’s Leaders.
PDS Biotechnology (NASDAQ: PDSB) is trading at 0.2894, up 31.55% from Friday’s 0.22 close. After opening at 0.4894 and rallying to 0.651, shares reversed sharply…
INVO Fertility (IVF) is soaring today, up 107.90% to 2.02 from Friday’s 0.9716 close, though it has pulled back from an intraday high of 2.80…
August 17, 2026
Femasys Bolsters Its Growth Plan With $30 Million Financing as FemBloc and FemaSeed Programs Advance
Key Points Femasys completed a $30 million private placement after June 30, with up to $60 million in potential additional proceeds if related warrants are…
August 04, 2026
DarioHealth Expands Its Provider-Backed Cardiometabolic Platform with New Women’s Health and Sleep Programs
Key Points DarioHealth Corp. is broadening its digital cardiometabolic platform with new women’s health and sleep-focused services. The company is adding provider-backed care and clinical…
July 28, 2026
Daré Bioscience Partners With MyMenopauseRx to Expand DARE to PLAY Access and Build a Women’s Health Ecosystem
Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven women’s health biotech company, announced a strategic collaboration with MyMenopauseRx on July 28, 2026, a telehealth platform focused…
INVO Fertility, Inc. (NASDAQ: IVF) is having another explosive session today, with the stock up more than 50% and recently trading around the mid‑1s after…
Hub Cyber Security Ltd. (NASDAQ: HUBC) is extending its wild run today, trading about 19% higher at 0.5704 after a previous close of 0.48. The…
As National Women’s Health Week 2026 unfolds, the financial narrative surrounding “FemTech” and specialized healthcare is undergoing a radical maturation. For decades, the field was…
January 12, 2026
JAZZ & Boehringer Partner to Advance Zanidatamab Strategy
Jazz Pharmaceuticals (NASDAQ: JAZZ) and Boehringer Ingelheim have officially launched a clinical trial collaboration. The partnership focuses on evaluating a new combination therapy for patients…
Greenwich LifeSciences (NASDAQ: GLSI) is having a strong session today, with the stock trading around the high‑teens and up roughly the high‑teens percentage-wise as it…